Inventor · disambiguated record
Kotaro Yoshioka
Also filed as: YOSHIOKA KOTARO
6 granted patents·6 pending applications·3 citations·filing 2014–2022
68Inventor score
Top patents by PatentIndex Score
12 records- 0176US11028387B2Double-stranded agents for delivering therapeutic oligonucleotidesUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2014·Granted Jun 8, 2021·2 cites·7 claims
- 0269US11260134B2Double-stranded nucleic acid complex having overhangUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2017·Granted Mar 1, 2022·1 cites·12 claims
- 0366US2022154185A1HETERO DOUBLE-STRANDED antimiRUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 0464US11851654B2Nucleic acid with reduced toxicityUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2019·Granted Dec 26, 2023·0 cites·15 claims
- 0562US2025179486A1Heteronucleic acid including 2'-modified nucleosideUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 0662US2024240183A1Heteronucleic acid containing scpBNA or AmNAUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2022·Application pending·0 cites
- 0756US10696640B2Fluoroalkylating agentKUMIAI CHEMICAL INDUSTRY CO·Filed 2019·Granted Jun 30, 2020·0 cites·6 claims
- 0853US2020115710A1HETERO DOUBLE-STRANDED antimiRUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2018·Application pending·0 cites
- 0950US10308613B2Fluoroalkylating agentKUMIAI CHEMICAL INDUSTRY CO·Filed 2015·Granted Jun 4, 2019·0 cites·8 claims
- 1041US10190117B2Double-stranded antisense nucleic acid with exon-skipping effectUNIV NAT CORP TOKYO MEDICAL & DENTAL·Filed 2014·Granted Jan 29, 2019·0 cites·14 claims
- 1133US2018223280A1Nucleic acid complexRENA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1233US2018228830A1Nucleic acid complex having at least one bulge structureRENA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →